Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay)

被引:192
作者
Jiang, ZD
Lowe, B
Verenkar, MP
Ashley, D
Steffen, R
Tornieporth, N
von Sonnenburg, F
Waiyaki, P
DuPont, HL
机构
[1] Univ Texas, Houston Sch Publ Hlth, Ctr Infect Dis, Houston, TX 77030 USA
[2] St Lukes Episcopal Hosp, Houston, TX 77030 USA
[3] Baylor Coll Med, Houston, TX 77030 USA
[4] Kenya Govt Med Res Ctr, Ctr Geog Med Res, Kilifi, Kenya
[5] Kenya Govt Med Res Ctr, Nairobi, Kenya
[6] Goa Med Coll, Bambolin, India
[7] Minist Hlth, Western Area Hlth Adm, Kingston, Jamaica
[8] Univ Zurich, Travel Clin, Zurich, Switzerland
[9] GlaxoSmithKline Biol, Rixensart, Belgium
[10] Univ Munich, Dept Infect Dis & Trop Med, Munich, Germany
关键词
D O I
10.1086/338834
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Stools from tourists from Europe and North America who acquired diarrhea in Mombasa (Kenya), Goa (India), or Montego Bay (Jamaica) were examined for enteric pathogens. Entero-toxigenic Escherichia coli (ETEC) was the most common pathogen (25%) identified in the 3 locations. Isolation of Shigella species was more frequent in Goa and Mombasa than in Montego Bay (10%, 9%, and 0.3%, respectively; P <.005). Viruses (rotaviruses and enteric adenoviruses) were found in 9% of travelers to the 3 areas. Of 275 ETEC isolates in this study, 158 (57%) produced a defined colonization factor antigen (CFA). Coli surface 6 (CS6) was the most frequent and was found in 41%-52% of CFA/CS-positive ETEC isolates. The frequency of resistance among bacterial enteropathogens to traditional antimicrobial agents was particularly high throughout the study period in all 3 regions. Quinolones were active against the bacterial enteropathogens in the 3 sites.
引用
收藏
页码:497 / 502
页数:6
相关论文
共 24 条
[1]   Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world [J].
Adachi, JA ;
Jiang, ZD ;
Mathewson, JJ ;
Verenkar, MP ;
Thompson, S ;
Martinez-Sandoval, F ;
Steffen, R ;
Ericsson, CD ;
DuPont, HL .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (12) :1706-1709
[2]  
AGUERO ME, 1985, J CLIN MICROBIOL, V22, P576
[3]   TRIMETHOPRIM SULFAMETHOXAZOLE REMAINS ACTIVE AGAINST ENTEROTOXIGENIC ESCHERICHIA-COLI AND SHIGELLA SPECIES IN GUADALAJARA, MEXICO [J].
BANDRES, JC ;
MATHEWSON, JJ ;
ERICSSON, CD ;
DUPONT, HL .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1992, 303 (05) :289-291
[4]   COLONIZATION FACTORS OF ENTEROTOXIGENIC ESCHERICHIA-COLI ISOLATED FROM CHILDREN WITH DIARRHEA IN ARGENTINA [J].
BINSZTEIN, N ;
JOUVE, MJ ;
VIBOUD, GI ;
MORAL, LL ;
RIVAS, M ;
ORSKOV, I ;
AHREN, C ;
SVENNERHOLM, AM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (09) :1893-1898
[5]  
BLACK RE, 1990, REV INFECT DIS, V12, pS73
[6]   Improved detection of enterotoxigenic Escherichia coli among patients with travelers' diarrhea, by use of the polymerase chain reaction technique [J].
Caeiro, JP ;
Estrada-Garcia, MT ;
Jiang, ZD ;
Mathewson, JJ ;
Adachi, JA ;
Steffen, R ;
DuPont, HL .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (06) :2053-2055
[7]   TRAVELERS DIARRHEA - APPROACHES TO PREVENTION AND TREATMENT [J].
ERICSSON, CD ;
DUPONT, HL .
CLINICAL INFECTIOUS DISEASES, 1993, 16 (05) :616-624
[8]   TRAVELERS DIARRHEA AND TOXIGENIC ESCHERICHIA-COLI [J].
GORBACH, SL ;
KEAN, BH ;
EVANS, DG ;
EVANS, DJ ;
BESSUDO, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (18) :933-936
[9]   CRYPTOSPORIDIOSIS ASSOCIATED WITH TRAVELING AND GIARDIASIS [J].
JOKIPII, L ;
POHJOLA, S ;
JOKIPII, AMM .
GASTROENTEROLOGY, 1985, 89 (04) :838-842
[10]   USE OF AZITHROMYCIN FOR THE TREATMENT OF CAMPYLOBACTER ENTERITIS IN TRAVELERS TO THAILAND, AN AREA WHERE CIPROFLOXACIN RESISTANCE IS PREVALENT [J].
KUSCHNER, RA ;
TROFA, AF ;
THOMAS, RJ ;
HOGE, CW ;
PITARANGSI, C ;
AMATO, S ;
OLAFSON, RP ;
ECHEVERRIA, P ;
SADOFF, JC ;
TAYLOR, DN .
CLINICAL INFECTIOUS DISEASES, 1995, 21 (03) :536-541